Nasdaq: SCYX

Scynexis, Inc.

Scynexis, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of novel anti-infectives to address unmet medical needs. The company’s lead product candidate is SCY-078 which is being developed for the treatment of invasive fungal infections.